Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Opioid receptor PET reveals the psychobiologic correlates of reward processing.
Schreckenberger M, Klega A, Gründer G, Buchholz HG, Scheurich A, Schirrmacher R, Schirrmacher E, Müller C, Henriksen G, Bartenstein P. Schreckenberger M, et al. Among authors: buchholz hg. J Nucl Med. 2008 Aug;49(8):1257-61. doi: 10.2967/jnumed.108.050849. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632824 Free article.
Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung.
Schirrmacher E, Schirrmacher R, Thews O, Dillenburg W, Helisch A, Wessler I, Buhl R, Höhnemann S, Buchholz HG, Bartenstein P, Machulla HJ, Rösch F. Schirrmacher E, et al. Among authors: buchholz hg. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2687-92. doi: 10.1016/s0960-894x(03)00538-9. Bioorg Med Chem Lett. 2003. PMID: 12873495
The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F, Gründer G, Bartenstein P, Vogt T. Schreckenberger M, et al. Among authors: buchholz hg. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1128-35. doi: 10.1007/s00259-004-1465-5. Epub 2004 Mar 23. Eur J Nucl Med Mol Imaging. 2004. PMID: 15042325 Clinical Trial.
Acute alcohol effects on neuronal and attentional processing: striatal reward system and inhibitory sensory interactions under acute ethanol challenge.
Schreckenberger M, Amberg R, Scheurich A, Lochmann M, Tichy W, Klega A, Siessmeier T, Gründer G, Buchholz HG, Landvogt C, Stauss J, Mann K, Bartenstein P, Urban R. Schreckenberger M, et al. Among authors: buchholz hg. Neuropsychopharmacology. 2004 Aug;29(8):1527-37. doi: 10.1038/sj.npp.1300453. Neuropsychopharmacology. 2004. PMID: 15085090 Clinical Trial.
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours.
Helisch A, Förster GJ, Reber H, Buchholz HG, Arnold R, Göke B, Weber MM, Wiedenmann B, Pauwels S, Haus U, Bouterfa H, Bartenstein P. Helisch A, et al. Among authors: buchholz hg. Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1386-92. doi: 10.1007/s00259-004-1561-6. Epub 2004 Jun 3. Eur J Nucl Med Mol Imaging. 2004. PMID: 15175836 Clinical Trial.
113 results